Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Scaffold subunits support associated subunit assembly in the Chlamydomonas ciliary nexin-dynein regulatory complex.

Gui L, Song K, Tritschler D, Bower R, Yan S, Dai A, Augspurger K, Sakizadeh J, Grzemska M, Ni T, Porter ME, Nicastro D.

Proc Natl Acad Sci U S A. 2019 Oct 28. pii: 201910960. doi: 10.1073/pnas.1910960116. [Epub ahead of print]

PMID:
31659045
2.

Tuberculosis and integrated child health - Rediscovering the principles of Alma Ata.

Detjen AK, Essajee S, Grzemska M, Marais BJ.

Int J Infect Dis. 2019 Mar;80S:S9-S12. doi: 10.1016/j.ijid.2019.02.042. Epub 2019 Feb 27. No abstract available.

3.

Molecular Discrimination between Two Conformations of Sphingomyelin in Plasma Membranes.

Endapally S, Frias D, Grzemska M, Gay A, Tomchick DR, Radhakrishnan A.

Cell. 2019 Feb 21;176(5):1040-1053.e17. doi: 10.1016/j.cell.2018.12.042. Epub 2019 Jan 31.

PMID:
30712872
4.

Chromomycin A2 potently inhibits glucose-stimulated insulin secretion from pancreatic β cells.

Kalwat MA, Hwang IH, Macho J, Grzemska MG, Yang JZ, McGlynn K, MacMillan JB, Cobb MH.

J Gen Physiol. 2018 Dec 3;150(12):1747-1757. doi: 10.1085/jgp.201812177. Epub 2018 Oct 23.

5.

High-resolution crystal structure of the human CB1 cannabinoid receptor.

Shao Z, Yin J, Chapman K, Grzemska M, Clark L, Wang J, Rosenbaum DM.

Nature. 2016 Dec 22;540(7634):602-606. doi: 10.1038/nature20613. Epub 2016 Nov 16.

6.

Executive Summary: Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.

Nahid P, Dorman SE, Alipanah N, Barry PM, Brozek JL, Cattamanchi A, Chaisson LH, Chaisson RE, Daley CL, Grzemska M, Higashi JM, Ho CS, Hopewell PC, Keshavjee SA, Lienhardt C, Menzies R, Merrifield C, Narita M, O'Brien R, Peloquin CA, Raftery A, Saukkonen J, Schaaf HS, Sotgiu G, Starke JR, Migliori GB, Vernon A.

Clin Infect Dis. 2016 Oct 1;63(7):853-67. doi: 10.1093/cid/ciw566.

7.

Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.

Nahid P, Dorman SE, Alipanah N, Barry PM, Brozek JL, Cattamanchi A, Chaisson LH, Chaisson RE, Daley CL, Grzemska M, Higashi JM, Ho CS, Hopewell PC, Keshavjee SA, Lienhardt C, Menzies R, Merrifield C, Narita M, O'Brien R, Peloquin CA, Raftery A, Saukkonen J, Schaaf HS, Sotgiu G, Starke JR, Migliori GB, Vernon A.

Clin Infect Dis. 2016 Oct 1;63(7):e147-e195. doi: 10.1093/cid/ciw376. Epub 2016 Aug 10.

8.

Interrupted BCG vaccination is a major threat to global child health.

Marais BJ, Seddon JA, Detjen AK, van der Werf MJ, Grzemska M, Hesseling AC, Curtis N, Graham SM; WHO Child TB Subgroup.

Lancet Respir Med. 2016 Apr;4(4):251-3. doi: 10.1016/S2213-2600(16)00099-0. Epub 2016 Mar 23. Review. No abstract available.

PMID:
27016867
9.

The background and rationale for a new fixed-dose combination for first-line treatment of tuberculosis in children.

Graham SM, Grzemska M, Gie RP.

Int J Tuberc Lung Dis. 2015 Dec;19 Suppl 1:3-8. doi: 10.5588/ijtld.15.0416.

PMID:
26564534
10.

Understanding Market Size and Reporting Gaps for Paediatric TB in Indonesia, Nigeria and Pakistan: Supporting Improved Treatment of Childhood TB in the Advent of New Medicines.

Coghlan R, Gardiner E, Amanullah F, Ihekweazu C, Triasih R, Grzemska M, Sismanidis C.

PLoS One. 2015 Oct 13;10(10):e0138323. doi: 10.1371/journal.pone.0138323. eCollection 2015.

11.

Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries.

Getahun H, Matteelli A, Abubakar I, Aziz MA, Baddeley A, Barreira D, Den Boon S, Borroto Gutierrez SM, Bruchfeld J, Burhan E, Cavalcante S, Cedillos R, Chaisson R, Chee CB, Chesire L, Corbett E, Dara M, Denholm J, de Vries G, Falzon D, Ford N, Gale-Rowe M, Gilpin C, Girardi E, Go UY, Govindasamy D, D Grant A, Grzemska M, Harris R, Horsburgh CR Jr, Ismayilov A, Jaramillo E, Kik S, Kranzer K, Lienhardt C, LoBue P, Lönnroth K, Marks G, Menzies D, Migliori GB, Mosca D, Mukadi YD, Mwinga A, Nelson L, Nishikiori N, Oordt-Speets A, Rangaka MX, Reis A, Rotz L, Sandgren A, Sañé Schepisi M, Schünemann HJ, Sharma SK, Sotgiu G, Stagg HR, Sterling TR, Tayeb T, Uplekar M, van der Werf MJ, Vandevelde W, van Kessel F, van't Hoog A, Varma JK, Vezhnina N, Voniatis C, Vonk Noordegraaf-Schouten M, Weil D, Weyer K, Wilkinson RJ, Yoshiyama T, Zellweger JP, Raviglione M.

Eur Respir J. 2015 Dec;46(6):1563-76. doi: 10.1183/13993003.01245-2015. Epub 2015 Sep 24. Review.

12.

WHO's new end TB strategy.

Uplekar M, Weil D, Lonnroth K, Jaramillo E, Lienhardt C, Dias HM, Falzon D, Floyd K, Gargioni G, Getahun H, Gilpin C, Glaziou P, Grzemska M, Mirzayev F, Nakatani H, Raviglione M; for WHO's Global TB Programme.

Lancet. 2015 May 2;385(9979):1799-1801. doi: 10.1016/S0140-6736(15)60570-0. Epub 2015 Mar 24. No abstract available.

PMID:
25814376
13.

Regional initiatives to address the challenges of tuberculosis in children: perspectives from the Asia-Pacific region.

Graham SM, Grzemska M, Brands A, Nguyen H, Amini J, Triasih R, Talukder K, Ahmed S, Amanullah F, Kumar B, Tufail P, Detjen A, Marais B, Hennig C, Islam T.

Int J Infect Dis. 2015 Mar;32:166-9. doi: 10.1016/j.ijid.2014.12.013.

14.

Adoption of revised dosage recommendations for childhood tuberculosis in countries with different childhood tuberculosis burdens.

Detjen AK, Macé C, Perrin C, Graham SM, Grzemska M.

Public Health Action. 2012 Dec 21;2(4):126-32. doi: 10.5588/pha.12.0052.

15.

Evaluation of tuberculosis diagnostics in children: 2. Methodological issues for conducting and reporting research evaluations of tuberculosis diagnostics for intrathoracic tuberculosis in children. Consensus from an expert panel.

Cuevas LE, Browning R, Bossuyt P, Casenghi M, Cotton MF, Cruz AT, Dodd LE, Drobniewski F, Gale M, Graham SM, Grzemska M, Heinrich N, Hesseling AC, Huebner R, Jean-Philippe P, Kabra SK, Kampmann B, Lewinsohn D, Li M, Lienhardt C, Mandalakas AM, Marais BJ, Menzies HJ, Montepiedra G, Mwansambo C, Oberhelman R, Palumbo P, Russek-Cohen E, Shapiro DE, Smith B, Soto-Castellares G, Starke JR, Swaminathan S, Wingfield C, Worrell C.

J Infect Dis. 2012 May 15;205 Suppl 2:S209-15. doi: 10.1093/infdis/jir879. Epub 2012 Apr 3.

16.

Evaluation of tuberculosis diagnostics in children: 1. Proposed clinical case definitions for classification of intrathoracic tuberculosis disease. Consensus from an expert panel.

Graham SM, Ahmed T, Amanullah F, Browning R, Cardenas V, Casenghi M, Cuevas LE, Gale M, Gie RP, Grzemska M, Handelsman E, Hatherill M, Hesseling AC, Jean-Philippe P, Kampmann B, Kabra SK, Lienhardt C, Lighter-Fisher J, Madhi S, Makhene M, Marais BJ, McNeeley DF, Menzies H, Mitchell C, Modi S, Mofenson L, Musoke P, Nachman S, Powell C, Rigaud M, Rouzier V, Starke JR, Swaminathan S, Wingfield C.

J Infect Dis. 2012 May 15;205 Suppl 2:S199-208. doi: 10.1093/infdis/jis008. Epub 2012 Mar 22.

17.

Prevention, diagnosis, and treatment of tuberculosis in children and mothers: evidence for action for maternal, neonatal, and child health services.

Getahun H, Sculier D, Sismanidis C, Grzemska M, Raviglione M.

J Infect Dis. 2012 May 15;205 Suppl 2:S216-27. doi: 10.1093/infdis/jis009. Epub 2012 Mar 22. Review.

PMID:
22448018
18.

Childhood tuberculosis: progress requires an advocacy strategy now.

Sandgren A, Cuevas LE, Dara M, Gie RP, Grzemska M, Hawkridge A, Hesseling AC, Kampmann B, Lienhardt C, Manissero D, Wingfield C, Graham SM.

Eur Respir J. 2012 Aug;40(2):294-7. doi: 10.1183/09031936.00187711. Epub 2012 Feb 15.

19.

WHO's relationship with the Stop TB Partnership.

Raviglione M, Nunn P, Floyd K, Getahun H, Grzemska M, Weil D, Weyer K.

Lancet. 2012 Feb 18;379(9816):611-2. doi: 10.1016/S0140-6736(12)60157-3. Epub 2012 Jan 30. No abstract available.

PMID:
22293368
20.

Children and tuberculosis medicines: bridging the research gap.

Hill S, Regondi I, Grzemska M, Matiru R.

Bull World Health Organ. 2008 Sep;86(9):658. No abstract available.

21.

Speaking the same language: treatment outcome definitions for multidrug-resistant tuberculosis.

Laserson KF, Thorpe LE, Leimane V, Weyer K, Mitnick CD, Riekstina V, Zarovska E, Rich ML, Fraser HS, Alarcón E, Cegielski JP, Grzemska M, Gupta R, Espinal M.

Int J Tuberc Lung Dis. 2005 Jun;9(6):640-5.

PMID:
15971391
22.

Encouraging outcomes in the first year of a TB control demonstration program: Orel Oblast, Russia.

Kherosheva T, Thorpe LE, Kiryanova E, Rybka L, Gerasichev V, Shulgina M, Nemtsova E, Aptekar T, Kluge H, Jakubowiak W, Grzemska M, Aquino G, Wells C, Kazionny B.

Int J Tuberc Lung Dis. 2003 Nov;7(11):1045-51.

PMID:
14598963
23.

American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis.

Blumberg HM, Burman WJ, Chaisson RE, Daley CL, Etkind SC, Friedman LN, Fujiwara P, Grzemska M, Hopewell PC, Iseman MD, Jasmer RM, Koppaka V, Menzies RI, O'Brien RJ, Reves RR, Reichman LB, Simone PM, Starke JR, Vernon AA; American Thoracic Society, Centers for Disease Control and Prevention and the Infectious Diseases Society.

Am J Respir Crit Care Med. 2003 Feb 15;167(4):603-62. No abstract available.

PMID:
12588714
24.

Frequency of recurrence among MDR-tB cases 'successfully' treated with standardised short-course chemotherapy.

Migliori GB, Espinal M, Danilova ID, Punga VV, Grzemska M, Raviglione MC.

Int J Tuberc Lung Dis. 2002 Oct;6(10):858-64.

PMID:
12365571
25.

Tuberculosis in prisons in countries with high prevalence.

Coninx R, Maher D, Reyes H, Grzemska M.

BMJ. 2000 Feb 12;320(7232):440-2. Review. No abstract available.

26.

Tuberculosis management in Europe. Task Force of the European Respiratory Society (ERS), the World Health Organisation (WHO) and the International Union against Tuberculosis and Lung Disease (IUATLD) Europe Region.

Migliori GB, Raviglione MC, Schaberg T, Davies PD, Zellweger JP, Grzemska M, Mihaescu T, Clancy L, Casali L.

Eur Respir J. 1999 Oct;14(4):978-92. No abstract available.

27.

Tuberculosis control in the Caucasus: successes and constraints in DOTS implementation.

Zalesky R, Abdullajev F, Khechinashvili G, Safarian M, Madaras T, Grzemska M, Englund E, Dittmann S, Raviglione M.

Int J Tuberc Lung Dis. 1999 May;3(5):394-401.

PMID:
10331728
28.

Cost-effectiveness analysis of tuberculosis control policies in Ivanovo Oblast, Russian Federation. Ivanovo Tuberculosis Project Study Group.

Migliori GB, Khomenko AG, Punga VV, Ambrosetti M, Danilova I, Ribka LN, Grzemska M, Sawert H, Raviglione MC.

Bull World Health Organ. 1998;76(5):475-83.

30.

[Cost benefit of detection and treatment patients with tuberculosis in Ivanovo region, Russian Federation].

Khomenko AG, Punga VV, Rybka LN, Grishina TA, Migliori DB, Ambrosetti M, Ravilyone M, Grzemska M, Stoiunin MB, Danilova ID, Filippova LV.

Probl Tuberk. 1998;(3):9-13. Russian.

PMID:
9691679
31.

Tuberculosis control in Kyrgyzstan--an opportunity.

Raviglione MC, Grzemska M, Alisherov AS, Limarev PI.

World Health Forum. 1996;17(1):85-90.

PMID:
8820154

Supplemental Content

Loading ...
Support Center